Heterogeneity of 5-fluorouracil radiosensitivity modulation in cultured mammalian cell lines
- 31 December 1992
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 24 (3) , 519-525
- https://doi.org/10.1016/0360-3016(92)91068-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumourRadiotherapy and Oncology, 1986
- Adjuvant treatment of rectal cancer: Randomized prospective study of irradiation ± chemotherapy — A NCCTG, Mayo clinic studyInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Survival after Postoperative Combination Treatment of Rectal CancerNew England Journal of Medicine, 1986
- The effect of combined modality therapy on local control and survivalInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Prolongation of the Disease-Free Interval in Surgically Treated Rectal CarcinomaNew England Journal of Medicine, 1985
- Phase I and pharmacologic study of 72-hour infused 5-fluorouracil and hyperfractionated cyclical radiationInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X raysInternational Journal of Radiation Oncology*Biology*Physics, 1982
- COMBINED 5-FLUOROURACIL AND SUPERVOLTAGE RADIATION THERAPY OF LOCALLY UNRESECTABLE GASTROINTESTINAL CANCERThe Lancet, 1969
- Effects of some Metabolic Inhibitors on X-ray Dose-response Curves for the Survival of Mammalian Cellsin vitro, and on Early Recovery between Fractionated X-ray DosesThe British Journal of Radiology, 1966
- The physiologic disposition of 5‐fluorouracil and 5‐fluoro‐2′‐deoxyuridine in manClinical Pharmacology & Therapeutics, 1964